A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, ...
Megakaryocytes (MKs), which are traditionally known for their role in platelet production, are now emerging as unique immune ...
Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and ...
Rese-cel, previously called CABA-201, is a CAR T-cell therapy that's designed to treat MS by depleting B-cells.
Kashmir's leading scientist and gastroenterologist, Prof M Sultran Khuroo writes about the evolution of the Human ...
The Phase 1 GALLOP study evaluating the investigational CAR-T therapy, CB-010, for treatment of lupus nephritis has launched.
Novel CD37 antibody-drug conjugate shows promise in targeting the Achilles’ heel of acute myeloid leukemia cells.
Researchers have discovered that mouse PD-1 is significantly weaker than human PD-1, calling into question their reliability ...
A groundbreaking study from Baylor College of Medicine explores how two types of CAR T cells target cancer, shedding light on ...
A study explores the molecular dynamics of CD28.ζ-CAR and 4-1BB.ζ-CAR T cells at the immune synapse, where CAR T cells bind ...
A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...
A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback